# The Effects of an Infant Formula Containing Hydrolysed Proteins on Growth and Tolerance in Healthy Term Infants

> **NCT05757323** · NA · COMPLETED · sponsor: **FrieslandCampina** · enrollment: 345 (actual)

## Conditions studied

- Growth

## Interventions

- **OTHER:** infant formula based on hydrolyzed protein
- **OTHER:** infant formula based on intact protein

## Key facts

- **NCT ID:** NCT05757323
- **Lead sponsor:** FrieslandCampina
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-06
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05757323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05757323, "The Effects of an Infant Formula Containing Hydrolysed Proteins on Growth and Tolerance in Healthy Term Infants". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05757323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
